Previous Article | Next Article ![]()
Journal of Bacteriology, May 2002, p. 2805-2814, Vol. 184, No. 10
0021-9193/02/$04.00+0 DOI: 10.1128/JB.184.10.2805-2814.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Lee R. Swem, and Carl E. Bauer*
Department of Biology, Indiana University, Bloomington, Indiana 47405
Received 10 October 2002/ Accepted 3 February 2002
|
|
|---|
|
|
|---|
In this study, we have identified a new transcription factor coded by an open reading frame (orf192) located just upstream of crtJ in the previously sequenced Rhodobacter capsulatus photosynthesis gene cluster (1). Disruption of orf192 indicates that it codes for an aerobic repressor (AerR) of carotenoids and bacteriochlorophyll and for the reaction center and light-harvesting apoproteins. The results of gel mobility shift assays indicate that AerR binds to the pufQ, crtA-crtI, and pucB promoters. Additionally, we show that AerR and CrtJ cooperatively interact with a subset of promoters that are aerobically repressed by both of these repressors.
|
|
|---|
(Novagen) was used for routine DNA cloning, and BL21(DE3)/pLysE was used for protein overproduction. E. coli strains S17-1
-pir (27) and HB101/pDPT51 (31) were used to mobilize plasmids into R. capsulatus. R. capsulatus strains were cultured photosynthetically under anaerobic conditions or aerobically at 34°C in PYS medium (34). E. coli strains were grown in Luria broth (24) or in Terrific broth (24) at 37°C. Appropriate antibiotics were used for plasmid and strain selections, with concentrations of 50 µg/ml for ampicillin and for kanamycin in E. coli. For R. capsulatus strains, antibiotic concentrations were 10 µg/ml for kanamycin, 10 µg/ml for spectinomycin, 10 µg/ml for gentamicin, and 50 µg/ml for rifampin.
Construction of aerR and crtJ reporter plasmids. Several lacZ-based reporter plasmids were constructed to assay the transcription of aerR and crtJ. The initial construction involved PCR amplification of a 3.2-kb aerR-crtJ DNA segment using primers Ose5 (5'-GAGCTCATCGCGTCCCCCGTT-3') and Ose6 (5'-GGTGGAAACGGTCCTGGAGCA-3'). The amplified product was cloned into the SrfI site of pPCR-Script SK(+) vector (Stratagene), creating the plasmid pES3. Fragments (0.64-kb NruI-MscI, 1.13-kb EcoRV-MscI, 0.74-kb MscI-HincII and 1.9-kb EcoRV-HincII fragments) were subcloned from pES3 and into plasmid pUC119 at the SmaI site by blunt-end ligation, yielding plasmids pES11, pES12, pES13, and pES14, respectively. Reporter plasmids pES15 and pES16 were constructed by insertion of the 0.64-kb KpnI-XbaI DNA fragment from pES11 and the 1.13-kb KpnI-XbaI fragment from pES12, respectively, into the KpnI and XbaI sites of the lacZ reporter plasmid pPHU236 (11). Reporter plasmids pES17 and pES18 were constructed by inserting the 0.74-kb KpnI-XbaI fragment from pES13 and the 1.9-kb KpnI-XbaI fragment from pES14 into KpnI-XbaI sites of pPHU234 (11). Reporter plasmids pES16 and pES18 also underwent deletion of a 0.9-kb KpnI-XhoI fragment, treated with T4 DNA polymerase and then blunt-end ligated, to construct reporter plasmids pESM16 and pESM18, respectively. The plasmids were introduced into the wild-type strain SB1003 by triparental mating as described by Nickens and Bauer (19).
Gene disruptions. A deletion of aerR, as well as a deletion of both aerR and crtJ, was constructed by the homologous recombination of a kanamycin resistance (Kanr) cassette into the chromosome. For constructing aerR deletion strains, a 1.1-kb BamHI fragment from pES3 was cloned into a BamHI site in pGEM-7Zf(+) (Promega), yielding plasmid pES7/8. A 346-bp BglII-StyI fragment from pES7/8 was blunt-end replaced with a 1.4-kb SmaI Kanr cassette that was isolated from pUC4KIXX (2) (Pharmacia Fine Chemicals). One resulting plasmid, pES7, has Kanr in the same orientation as aerR-crtJ, and the second plasmid, pES8, has the Kanr cassette in the opposite orientation to that of aerR-crtJ.
An aerR-crtJ double-deletion strain was made by replacing both genes with the Kanr cassette. In brief, a 567-bp fragment upstream of aerR was PCR amplified by using primers 5'-GGAGTTCGGCATAGTGGC A-3' and 5'-GGAGATCTCCAAGCTCCGGTCCCG-3', which introduced a BglII site (restriction sites are underlined) to the primer that was closest to aerR. A 729-bp fragment downstream of crtJ was also PCR amplified by using primers 5'-CCAGATCTCAACGCCTGCTCCAGGAC-3' and 5'-CCTCTAGATAGATCGACGGCGTGATCGA-3', with a BglII site present in the primer closest to the crtJ coding region and an XbaI added to the primer furthest from crtJ (underlined). The two DNA segments were subcloned into pBluescript II SK(±) separately to generate pBluescript::uporf19 2 and pBluescript::downcrtJ. The BglII-HindIII fragment from pBluescript::downcrtJ and a Kanr DNA fragment flanked by BamHI-cut sites that was isolated from pBSL15 were together inserted into pBluescript::uporf192 between BglII and XbaI sites to generate the plasmid pCD3, which has the Kanr cassette in the same orientation as aerR-crtJ. This construct has the Kanr DNA fragment in the same orientation as aerR-crtJ.
For disruption of the chromosomal copy of aerR, plasmids pES7 and pES8 were introduced into HB101/pDPT51 and then transferred into SB1003 by biparental conjugation as described earlier by Young et al. (34). Allelic replacement of the aerR::Kanr DNA segments from plasmids pES7 and pES8 into the genome of SB1003 generated strains ES7 and ES8, respectively. The aerR-crtJ deletion strain was constructed by homologous recombination using gene transfer agent-mediated allelic replacement (25) of the aerR::Kanr::crtJ DNA segment from plasmid pCD3 into the chromosome of SB1003, resulting in strain CD3. Each of the gene disruptions was confirmed by PCR amplification and DNA sequence analysis.
Immunodetection analysis. In vivo levels of CrtJ in the wild-type strain SB1003 and in the aerR-disrupted strains ES7 and ES8 were measured by the addition of an in-frame FLAG epitope to the carboxyl terminus of CrtJ (Scientific Imaging Systems; Eastman Kodak Co.). For epitope plasmid construction, the CrtJ coding sequence was PCR amplified using primers, 5'-CAAGCTTATGCGACGGGAGGCCTTG-3' and 5'-GCAGATCTCCGCGTCCTTCGACAACAG-3', which contain HindII and BglII sites, respectively (underlined). The amplified segment was cloned into pBluescript II SK(±), from which a HindIII-BglII fragment was then subcloned into HindIII and BamHI sites in pJM23 (12). The resulting construct had crtJ fused in frame with a 7-amino-acid-long FLAG epitope followed by a stop codon. A CrtJ-FLAG DNA fragment was then isolated as a HindIII-SpeI fragment, blunt ended, and subcloned into an SmaI site of the suicide vector pZJD3 (12). The resulting plasmid was then recombined into the chromosomes of strains SB1003, ES7, and ES8 by homologous recombination by selecting for gentamicin resistance. Proper integration was confirmed by PCR amplification and DNA sequence analysis.
The expression levels of FLAG-tagged CrtJ in the recombinant strains SB1003-FLAG, ES7-FLAG, and ES8-FLAG were examined by Western blot analysis by using the FLAG epitope-specific monoclonal antibody M2 as a primary antibody as described by the supplier (Sigma) and a chemiluminescence-based horseradish peroxidase-linked secondary antibody (ECL Western blotting detection system; Amersham Pharmacia Biotech). Cells were harvested at a culture density of 100 Klett units by centrifugation at 7,649 x g for 5 min. The cell pellets were resuspended in a buffer containing 50 mM Tris-HCl (pH 8.0), with equal volumes of cell suspensions subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot analysis.
ß-Galactosidase assay and spectral analysis. Cells were grown photosynthetically or aerobically in PYS medium to a cell density of approximately 65 Klett units. For analysis of crtI, bchC, puc, and pufQ expression, cell extracts were prepared and assayed for ß-galactosidase activity as described by Young et al. (34). For measuring crtJ and aerR expression, ß-galactosidase activity was measured as described by Miller (16) using modifications described by Elsen et al. (10). Protein concentration was determined by the method of Bradford (6) (Bio-Rad).
For spectral analysis, cells were grown to a density of approximately 50 Klett units, chilled to 0°C, harvested by centrifugation at 8,000 x g for 10 min, and resuspended in 1/10 volume of 10 mM Tris-HCl, pH 8.0, and 1 mM EDTA. The cells were then disrupted by sonication and clarified by centrifugation at 8,000 x g for 10 min, and the supernatant was scanned for absorbency.
AerR and CrtJ purification. Forward and reverse primers 5'-CCATGGACCTGCTGTTCGACG-3' and 5'-GGATCCCAGTCATACCAGAGA-3' were used to amplify the aerR coding sequence that contains NcoI and BamHI sites (underlined), respectively. The amplified fragment was cloned into pBluescript II SK(±) and was subsequently introduced into pET32(a) (+) (Novagen Corp.) between NcoI and BamHI to generate the overexpression plasmid pET32(a) (+)::aerR. The plasmid was transformed into E. coli strain BL21(DE3) pLysE (28), and a His6-Trx-AerR fusion protein was overexpressed in 4 liters of Terrific broth by induction with 0.5 mM isopropyl-ß-D-thiogalactopyranoside (IPTG) at 25°C for 4 h. Cells were harvested and resuspended in 50 ml of ice-cold 1x loading buffer (5 mM imidazole, 0.5 M NaCl, and 20 mM Tris-HCl, pH 7.9) and were lysed by three passages through a chilled French pressure cell at 18,000 lb/in2. The lysate was clarified by centrifugation at 26,890 x g for 30 min, after which the supernatant was filtered through a 0.45-µm-pore-size Acrodisc (HT Tuffryn membrane; Gelman Sciences). The clarified supernatant was loaded on an Ni2+ column, washed with at least 40 volumes of 1x loading buffer, and eluted with 1x washing buffer (60 mM imidazole, 0.5 M NaCl, and 20 mM Tris-HCl, pH 7.9). Elution fractions were pooled and dialyzed overnight at 4°C against TPAE buffer composed of 50 mM Tris-HCl (pH 8.0), 200 mM potassium acetate, and 1 mM EDTA. The AerR protein was further purified by incubation with S-protein agarose beads at 4°C overnight and was eluted with 3 M MgCl2. The purified protein was dialyzed against TPAE buffer containing 20% glycerol overnight at 4°C and was stored at -80°C.
A His6 derivative of CrtJ that was used in gel mobility shift assays in this study was isolated from E. coli as described by Ponnampalam and Bauer (21). The percent active protein fraction was assayed as described by Ponnampalam and Bauer (21).
Gel mobility shift assay. 32P-labeled DNA probes containing either the bchC, pucB, pufQ, or crtIA promoter region were prepared by PCR amplification as previously described (21). Primers 5'-CAATTCGACCTGAAAATTCC and 5'-AAGCTCTCTCGGTTAAGTTC-3' were used to amplify a 464-bp pucB promoter region containing two TGT-N12-ACA CrtJ-binding palindromes. Primers 5'-CGGACATTATGACGACTTGCG-3' and 5'-TTCACCAAGGTGTCGAAACCG-3' were used to amplify a 262-bp bchC promoter region, and primers 5'-CGCGGTTTGATCCGCCAA A-3' and 5'-GCAGCACTGTCCATTTCGGAA-3' were used to amplify a 263-bp pufQ promoter region. A 300-bp crtI-crtA promoter region containing two CrtJ palindromic sequences was amplified by using primers 5'-CGGCGGGACAGGATCATCT-3' and 5'-GCCAAGGCCGGCACCGAT-3'. For testing the cooperation between CrtJ and AerR, two additional DNA fragments of each of the pucB promoter were amplified, with each of them containing only one TGT-N12-ACA palindrome. Primers 5'-CCATCGCCCGATCTGCGA-3' and 5'-CCAGACGCATCTTTGGGCGA-3' were used to amplify a 221-bp pucB promoter segment containing the upstream TGT-N12-ACA palindrome, and primers 5'-GCGCCACCGGCC CCGGAAT-3' and 5'-GCTGCCGGACCGTCTGTGAT-3' were used to amplify a 181-bp pucB promoter segment containing the downstream palindrome. All of the DNA probes described above were purified by electrophoresis in a 5% nondenaturing polyacrylamide gel and were recovered by electroelution.
For gel mobility shift assays, various amounts of purified AerR protein were added to 20 µl of reaction buffer composed of 4 fmol of 32P-labeled DNA probe, 0.6 µg of heparin as a competitor (800- to 1,000-fold excess by weight relative to the DNA probe), 5 mM HEPES (pH 7.8), 4 µg of bovine serum albumin/ml, 2% glycerol, 0.2 mM dithiothreitol, 2 mM MgCl2, and 20 µM EDTA. The reaction mixture was incubated at room temperature for 30 min and was subjected to a nondenaturing 4% Tris-glycine-EDTA-buffered polyacrylamide gel and was electrophoresed at room temperature for 2 h at 20 mA.
For cooperative binding of CrtJ and AerR, different amounts of purified His-tagged CrtJ were incubated with a 32P-labeled DNA segment of pucB or crtI promoter in the presence or absence of Trx-AerR. The relative amount of radioactivity in each shifted band was quantitated using a PhosphorImager (Molecular Dynamics) with the percentage of DNA probes bound to protein plotted versus the CrtJ concentration. Curves were plotted with a SigmaPlot program using the equation F = Y0 + a/{1 + exp[- (x - x0)/b]} (c) from which the 50% effective concentration (EC50) was estimated.
|
|
|---|
![]() View larger version (23K): [in a new window] |
FIG. 1. Expression patterns of aerR and crtJ. (A) ß-Galactosidase activities of various aerR and crtJ reporter plasmids in the wild-type strain SB1003 cells grown under aerobic (black bars) and anaerobic (open bars) conditions. ONP, o-nitrophenyl-ß-D-galactopyranoside. (B) Anaerobic and aerobic ß-galactosidase activities present in various regulatory mutant strains containing plasmid pES15. Wild type is strain SB1003, crtJ is strain CD2-4, aerR is strain ES8, and regA is strain MS01. ß-Galactosidase values represent the average of at least three independent assays.
|
Phenotypic effects of aerR disruption. The phenotypes of two aerR-disrupted strains were characterized. Strain ES7 was constructed; it replaced codons 59 to 175 of aerR with a DNA fragment coding for a Kanr gene that is in the same orientation as aerR and crtJ. Strain ES8 has the same aerR DNA segment (codons 59 to 175) replaced with the same Kanr gene, which is in the orientation opposite to that of aerR and crtJ (Fig. 2A).
![]() View larger version (19K): [in a new window] |
FIG. 2. Assays for polarity of the aerR::Kanr insertion mutations. (A) Strains ES7 and ES8 contain the same Kanr gene insertion in two different orientations. (B) Spectral analysis of membrane fractions from the wild-type strain SB1003, the two aerR-disrupted mutants ES7 and ES8, and the crtJ-disrupted strain CD2-4, grown under anaerobic conditions. (C) Immunoblot analysis of the amounts of FLAG CrtJ synthesized in strains SB1003-FLAG, ES8-FLAG, and ES7-FLAG.
|
To address the different phenotypes exhibited by the aerR-disrupted strains, we explored the possibility of polar effects on expression of crtJ. The in vivo expression levels of CrtJ were directly assayed by constructing epitope-tagged chromosomal versions of crtJ in the wild-type strain SB1003 as well as in the aerR-disrupted strains ES7 and ES8, leading to strains SB1003-FLAG, ES7-FLAG, and ES8-FLAG, respectively. Western blot analysis was then performed on whole-cell extracts to measure CrtJ-FLAG levels using a monoclonal antibody to the FLAG epitope tag. Strain ES8-FLAG, which has the Kanr cassette in the orientation opposite to that of crtJ, had a level of CrtJ-FLAG that was indistinguishable from that of SB1003-FLAG, which had no disruption of aerR (Fig. 2C). This indicates that elevated aerobic pigment biosynthesis observed in strain ES8 is not a consequence of polarity on crtJ expression. In contrast, the amount of CrtJ in strain ES7-FLAG, which has the Kanr gene inserted in aerR in the same orientation as is crtJ, is approximately 20-fold higher, as measured by densitometric scanning of the autoradiograph, than the level observed in strain SB1003-FLAG (Fig. 2C). Presumably the Kmr gene promoter inserted into aerR in strain ES7 drives increased transcription of crtJ, which leads to its overexpression and subsequent reduction of pigment levels.
As discussed below, genetic evidence indicates that bchC expression is regulated by CrtJ but not by AerR. Thus, the effect of increasing CrtJ concentration on bch gene expression can readily be assayed by measuring ß-galactosidase activity in SB1003 and ES7 cells that harbor the bchC::lacZ expression plasmid pDAY23
(34). The ß-galactosidase levels in the bar graph in Fig. 3A show that overexpression of CrtJ in strain ES7 resulted in a 50-fold reduction in bchC::lacZ expression. This also indicates that reduced pigment biosynthesis observed in ES7 is likely caused by increased repression of bch gene expression by overexpressed CrtJ.
![]() View larger version (23K): [in a new window] |
FIG. 3. (A) ß-Galactosidase analysis of bchC::lacZ expression from aerobically grown SB1003, ES7, ES7B, ES7C, and CD2-4 cells containing plasmid pDAY23 . The ß-galactosidase activities are the means of three independent analyses, with the values representing micromoles of o-nitrophenyl-ß-D-galactopyranoside hydrolyzed per minute per milligram of protein. Standard deviations are indicated by the error bars. (B) Alignment of the helix-turn-helix DNA-binding region of CrtJ and PpsR. The lengths (in amino acid numbers) of the two proteins are indicated in brackets. The mutated codons that are found in the photosynthetically competent suppressors of strain ES7 are indicated with an arrow.
|
We also assayed bchC::lacZ expression in the two suppressor strains ES7B and ES7C, which harbored the bchC expression plasmid pDAY23
. The bar graph in Fig. 3A shows that bchC::lacZ expression was significantly elevated in the two suppressor strains relative to that observed in ES7. Indeed, the level of bchC::lacZ expression observed in the suppressor strains is comparable with that observed for strain CD2-4, which contains a deletion of crtJ (Fig 3A). We can conclude from these suppressor studies that reduced pigment production in strain ES7 is indeed a consequence of constitutive suppression of bch and crt gene expression, which is caused by overproduction of CrtJ.
Disruption of aerR leads to elevated photosynthesis gene expression. ß-Galactosidase activity was analyzed from aerobically grown derivatives of strain ES8, which contained plasmids with lacZ translational fusions to different photosynthesis genes. For comparison, we assayed in parallel the gene expression patterns of wild-type cells, cells of the crtJ-disrupted strain CD2-4 (5), and cells of strain CD3, which contains a deletion of both aerR and crtJ. As shown in Fig. 4, disruption of aerR in strain ES8 resulted in elevated expression of the puc::lacZ and crtI::lacZ reporter genes to a level that is slightly above that of the crtJ-disrupted strain CD2-4. Deletion of both aerR and crtJ in strain CD3 resulted in additional elevation of puc and crtI gene expression beyond that observed with disruption of aerR or crtJ alone. Interestingly, disruption of aerR shows no effect on expression of the bchC gene as assayed with a bchC::lacZ reporter plasmid (Fig. 4). However, bchC expression was elevated in the crtJ mutant to a level similar to that previously reported, with no additional elevation in gene expression upon disruption of both aerR and crtJ. We also observed that aerR is involved in aerobic repression of the puf operon (Fig. 4), which codes for the light harvesting-I and reaction center structural genes, as based on elevated expression of a pufQ::lacZ reporter plasmid in strain ES8. This is an operon that is not under the control of CrtJ (Fig. 4) (22). Expression of the puf operon is also not enhanced in the double-deletion strain over that observed with the single disruption of aerR. Based on the different gene expression patterns exhibited by the aerR and the crtJ deletion strains, we can conclude that the phenotype exhibited by disrupting aerR is not a consequence of affecting crtJ expression.
![]() View larger version (28K): [in a new window] |
FIG. 4. Measurement of photosynthesis gene expression in the wild-type strain SB1003, in the crtJ-disrupted strain CD2-4, in the aerR-disrupted strain ES8, and in the strain CD3 with a deletion of aerR-crtJ. The four graphs represent aerobic expression levels of the pucB::lacZ fusion plasmid pLHIIZ (26), the crtI::lacZ fusion plasmid pCrtI:Z , the bchC::lacZ fusion plasmid pDAY23 , and the pufQ::lacZ fusion plasmid pCB532 (4). ß-Galactosidase activities are as described for Fig. 3.
|
![]() View larger version (26K): [in a new window] |
FIG. 5. Gel mobility shift assays with purified AerR. The first lane of each gel had only 32P-labeled probe and heparin (1,000-fold excess), while the second lane had the same probe and heparin preincubated with 2 µM AerR. puc, crtAI, puf, and bchC represent the various promoter probes that were used with each probe containing two CrtJ recognition sequences. P- represents the mobility of the unshifted probe, while -S represents the mobility of the AerR-shifted probe.
|
Figure 6A shows the results of a typical gel mobility shift cooperativity experiment for the puc promoter probe that contains only the downstream CrtJ DNA-binding site. Lanes 2 through 4 demonstrate that CrtJ does not bind to this probe at relatively low concentrations of 141 and 281 nM and binds only a slight percentage of shifted probe at a CrtJ concentration of 656 nM. Lanes 5 to 7 demonstrate that there is also no shift of the probe in the presence of AerR at a concentration of 24, 48, or 72 nM. However, lanes 8 to 10 show that incubation of 141 nM CrtJ, with as little as 24 nM AerR, results in a noticeable gel shift. There is nearly a complete shift of the DNA probe when 141 nM CrtJ is incubated with 72 nM AerR (lane 10). In the presence of 281 and 656 nM CrtJ (lanes 11 to 16), even less AerR is required to observe a shift of the probes. Therefore, the presence of both proteins clearly enhanced their individual DNA-binding affinities.
![]() View larger version (61K): [in a new window] |
FIG. 6. Cooperation between AerR and CrtJ in binding to the puc promoter region. (A) Gel mobility shift of CrtJ binding to the downstream puc palindrome in the absence or presence of AerR. Lane 1 is of probe only, while lanes 2 to 4 contain probe plus CrtJ at 141, 281, and 656 nM, respectively. Lanes 5 to 7 contain AerR at 24, 48, and 72 nM, respectively. Lanes 8 to 10 contain CrtJ at 141 nM in all lanes, as well as AerR at 24, 48, and 72 nM, respectively. Lanes 11 to 13 contain 281 nM CrtJ in each lane as well as AerR at 24, 48, and 72 nM, respectively. Lanes 14 to 16 contain 656 nM CrtJ in each lane as well as AerR at 24, 48, and 72 nM, respectively. (B) The graphs show a plot of the percentage of shifted 32P-labeled pucB probe versus the amount of CrtJ in the assay. Filled circles represent the DNA-binding isotherm of CrtJ with no AerR present, empty circles represent the CrtJ DNA-binding isotherm obtained in the presence of 24 nM AerR, and filled inverted triangles represent the CrtJ DNA-binding isotherm obtained in the presence of 48 nM AerR. The left, middle, and right graphs represent the binding curves obtained with a probe containing only the upstream CrtJ recognition palindrome, with a probe containing only the downstream recognition palindrome, and with a probe containing both recognition palindromes, respectively.
|
|
|
|---|
![]() View larger version (8K): [in a new window] |
FIG. 7. A diagram depicting CrtJ and AerR circuits that repress individual transcripts. Both proteins affect transcription initiation (lines with a single arrowhead) at promoters that contain distantly removed CrtJ recognition palindromes (lines with double arrows). Only CrtJ represses the bchC promoter that contains two closely spaced palindromes (8 bp apart), and only AerR represses the puf promoter, which does not contain CrtJ recognition palindromes.
|
Previous studies have indicated that CrtJ-repressed promoters fall into two classes. One class, represented by the bchC promoter, has two closely spaced CrtJ recognition palindromes located just 8 bp apart, with one overlapping the -35 promoter region and the other the -10 promoter region (23). Mutational studies have demonstrated that binding of CrtJ to the bchC promoter involves cooperative interactions between CrtJ bound at the -35 palindrome and CrtJ bound at the -10 palindrome (23). Mutations that increase or decrease the spacing between these palindromes disrupt cooperative interactions between CrtJ repressors that are bound to these two sites. AerR does not appear to affect CrtJ-mediated repression of this class of promoters. The second class of CrtJ-repressed promoters also has two CrtJ recognition palindromes, with the difference being that these palindromes are distantly removed (9). In the puc operon, one CrtJ palindrome is located at the -35 promoter region and the second palindrome is located 240 bp upstream (9). In the crtA-crtI promoter region, the palindromes are 76 bp apart, with one palindrome overlapping the -35 region of the crtI promoter and the other overlapping the -10 region of the crtA promoter (9). One model is that AerR may have a role in stabilizing the binding of CrtJ, which is known to exist in solution as a tetramer, to one of the distant binding sites. Previous mutational and in vitro DNA-binding studies have indicated that CrtJ cooperatively binds to the distantly removed palindromes in the puc and crtA-crtI promoters (9). This suggests that the DNA must loop around, allowing coordinate interaction of CrtJ to these distant sites. Figure 8 depicts a model that we favor, in which AerR may have a role in bending the DNA that would facilitate the interaction of CrtJ tetramers to distantly removed recognition sites. The DNA-binding curves for CrtJ binding to the puc probe in the presence and absence of AerR initially indicate that AerR is capable of stimulating CrJ binding to the DNA probes at substoichiometric levels. However, studies have indicated that E. coli-overexpressed, purified CrtJ contains a significant fraction that is inactive for DNA binding. When correcting for the percent active fraction of CrtJ that is capable of DNA binding (Table 1 [21]), we find that an excess of AerR is actually needed to promote maximal binding of CrtJ to the full-length puc probe that contains both palindromes. Thus, it is possible that AerR may be binding to the intervening sequence between the CrtJ recognition palindromes to facilitate DNA bending. Additional DNA-binding and DNase I footprint studies are ongoing with AerR and AerR plus CrtJ to specifically address aspects of this model.
![]() View larger version (28K): [in a new window] |
FIG. 8. A model depicting possible interactions between CrtJ and AerR at promoters that contain distantly spaced palindromes. The number of AerR symbols drawn relative to that of CrtJ symbols is arbitrary.
|
|
View this table: [in a new window] |
TABLE 1. Corrected EC50s for CrtJ binding to the puc promoter region in presence and absence of AerRa
|
This work was supported by National Institutes of Health grant GM53940 to C.E.B.
Present address: Laboratoire de Biochimie et Biophysique des Systèmes Intégrés, DBMS/CEA-Grenoble 38054, Grenoble Cedex 09, France. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»